PAREXEL International Corporation (PRXL) – Analysts’ Weekly Ratings Changes

PAREXEL International Corporation (PRXL) – Analysts’ Weekly Ratings Changes

Several analysts have recently updated their ratings and price targets for PAREXEL International Corporation (NASDAQ: PRXL):

Shares of PAREXEL International Corporation (NASDAQ:PRXL) traded down 0.30% during mid-day trading on Friday, hitting $69.98. The company had a trading volume of 528,249 shares. The company has a market capitalization of $3.73 billion, a PE ratio of 22.42 and a beta of 0.89. The company’s 50-day moving average is $67.24 and its 200 day moving average is $65.69. PAREXEL International Corporation has a one year low of $51.16 and a one year high of $72.32.

PAREXEL International Corporation (NASDAQ:PRXL) last released its earnings results on Wednesday, October 26th. The company reported $0.76 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.86 by $0.10. PAREXEL International Corporation had a return on equity of 30.71% and a net margin of 7.09%. The firm earned $500.90 million during the quarter, compared to analysts’ expectations of $525.15 million. During the same period in the prior year, the business earned $0.70 earnings per share. The business’s quarterly revenue was down 2.2% compared to the same quarter last year. On average, equities research analysts forecast that PAREXEL International Corporation will post $3.75 EPS for the current fiscal year.

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Related posts

Leave a Comment